Visalytics
Visalytics
approved EB-2 (NIW)

Internal Medicine Resident

Human Molecular Genetics · Israel · 2024-12-17

Processing Time
56 days
Decision Date
2024-12-17
Location
Ohio
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical national healthcare priorities, specifically neurodegenerative diseases like Alzheimer's.

2 Well Positioned to Advance the Endeavor Met

The petitioner is uniquely positioned through dual M.D./Ph.D. qualifications and a strong record of highly-cited research and federal funding.

3 Waiver Benefit Met

On balance, the petitioner’s contributions to genetic research and medical innovation outweigh the requirement for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. and Ph.D. degrees and a record of 12 peer-reviewed journal articles which garnered 465 citations. The petitioner also demonstrated authority in the field by completing at least 33 peer reviews for top-tier cell biology and molecular science journals. Approval was further supported by funding from the U.S.–Israel Binational Science Foundation and the National Science Foundation, alongside two expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions

Similar Cases

Scientist

Biotechnology · Zimbabwe

WeGreened EB-2 (NIW) approved
Massachusetts 297 days 2025-03-06
The petitioner proposes to develop safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her work specifically focuses on uncovering how protofibrils contribute to neuronal damage in Alzheimer’s disease to support the development of targeted drug therapies.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 97 days 2022-06-16
The petitioner proposes to continue her research in molecular biology, specifically focusing on the molecular origins of neurological disorders such as Alzheimer’s and Parkinson’s disease. Her work involves studying progressive neurodegeneration to improve treatments for patients with these conditions and advancing the brain's ability to transmit information across various systems.
View Case

Researcher

Research and Development · Nepal

WeGreened EB-2 (NIW) rfe approved
Missouri 327 days 2022-10-06
The petitioner proposes to continue her research on analyzing the genetic networks underlying Alzheimer’s disease. Her work focuses on developing early diagnostic procedures and effective treatments for neurodegenerative diseases.
View Case

Physician

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
District of Columbia 14 days 2023-02-22
The petitioner proposes to research the genetic basis and molecular pathogenesis of pediatric disorders and schizophrenia. His work focuses on identifying genetic mutations to develop novel diagnostic methods and targeted therapeutic treatments for rare genetic conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Israel

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-12-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 56 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Israel All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist